Comerica Securities’s Charles River Laboratories CRL Stock Holding History

Comerica Securities’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-267	Closed	-$58.2K	–	676
2022 Q4	$58.2K	Buy	+267	New	+$58.3K	﹤0.01%	684
2021 Q2	–	Sell	-1,052	Closed	-$305K	–	478
2021 Q1	$305K	Sell	1,052 -15	-1%	-$4.17K	0.02%	406
2020 Q4	$267K	Sell	1,067 -4	-0.4%	-$953	0.02%	407
2020 Q3	$243K	Sell	1,071 -118	-10%	-$24.5K	0.02%	387
2020 Q2	$207K	Buy	+1,189	New	+$190K	0.02%	412

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Comerica Securities's CRL Position: Q1 2023 in Review

Comerica Securities sold out of Charles River Laboratories (CRL) in Q1 2023, closing a stake of 267 shares — an estimated $58.2K sold.

Comerica Securities first reported a position in CRL in Q2 2020 and held it in 5 quarters. The position peaked at $305K in Q1 2021. 620 funds tracked by Wall St. Rank hold CRL as of Q1 2023.

Comerica Securities reported no remaining Charles River Laboratories position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 267 Charles River Laboratories shares in Q1 2023, an estimated $58.2K.
Comerica Securities first reported a position in Charles River Laboratories in Q2 2020 and held it in 5 quarters.
Comerica Securities's Charles River Laboratories position peaked at $305K in Q1 2021.
620 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.